Dopamine control of gene expression in basal ganglia nuclei: striatal and nonstriatal mechanisms.
Chesselet
M F
MF
Department of Neurology, UCLA School of Medicine 90095, USA.
Delfs
J M
JM
Mackenzie
L
L
D000818:Animals; D001479:Basal Ganglia / Q000378:metabolism*; D003342:Corpus Striatum / Q000502:physiology*; D004298:Dopamine / Q000502:physiology*; D005786:Gene Expression Regulation / Q000187:drug effects / Q000502:physiology*; D005917:Globus Pallidus / Q000378:metabolism; D005968:Glutamate Decarboxylase / Q000096:biosynthesis*; D006220:Haloperidol / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism; D009479:Neuropeptides / Q000096:biosynthesis*; D015221:Potassium Channels / Q000096:biosynthesis*; D024642:Potassium Channels, Voltage-Gated; D012333:RNA, Messenger / Q000096:biosynthesis; D051670:Shaw Potassium Channels; D014158:Transcription, Genetic / Q000187:drug effects; D005680:gamma-Aminobutyric Acid / Q000096:biosynthesis
D009479:Neuropeptides; D015221:Potassium Channels; D024642:Potassium Channels, Voltage-Gated; D012333:RNA, Messenger; D051670:Shaw Potassium Channels; D005680:gamma-Aminobutyric Acid; D005968:Glutamate Decarboxylase; D006220:Haloperidol; D004298:Dopamine